Aether Industries LimitedQ1 FY27 Results & Financial Update
Aether Industries Limited: Q1 FY27 consolidated results and company financials – revenue ₹326.56 Cr, PAT ₹62.75 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Aether Industries price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Aether Industries Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Aether Industries reported consolidated revenue from operations of INR 326.56 crore for the first quarter ended June 30, 2026, alongside total income of INR 334.25 crore.
Profit after tax for Q1 FY27 reached INR 62.75 crore, delivering a net profit margin of 19.22% based on total income, supported by a favorable shift in segment mix towards higher-value contract manufacturing models.
Operating profitability remained robust during the quarter, with EBITDA recorded at INR 102.76 crore and profit before tax standing at INR 83.45 crore.
The period marked the commercial commencement of the first phase of Site 5 (Magnum), featuring two new production blocks that are slated to begin contributing to commercial revenues from Q2 FY27 onwards.
The company onboarded 10 new customers across its various business models during the quarter and successfully completed nine customer and certification audits.
Research and development expenditure stood at INR 19.81 crore, representing 6.16% of revenues for the quarter, reflecting the company's continued emphasis on product innovation and process chemistry.
Profit after tax was ₹62.75 Cr for the reported quarter. EPS was ₹4.76 for the reported quarter.
01 · Business model
What does Aether Industries do?
Aether Industries Limited operates in the specialty chemicals sector, focusing on advanced organic chemistry, complex intermediates, and new-technology commercialization.
The company generates its revenue across three core business models: Contract / Exclusive Manufacturing (CEM), Contract Research & Manufacturing Services (CRAMS), and Large Scale Manufacturing (LSM) of proprietary products.
Its manufacturing infrastructure is based in Sachin, Surat, Gujarat, comprising multiple specialized plant sites designed for hazardous, complex chemistries and continuous manufacturing processes.
The customer base spans major global and domestic industries including pharmaceuticals, oil and gas, material science, agrochemicals, high-performance photography, and coatings.
02 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹326.56 Cr |
| Total income | ₹334.25 Cr |
| Profit before tax | ₹83.45 Cr |
| Profit after tax | ₹62.75 Cr |
| EPS | ₹4.76 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 19.2% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 25.6% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹7.69 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Growth in Contract and Exclusive Manufacturing (CEM) contracts, alongside price-led demand in Large Scale Manufacturing (LSM), drove overall topline expansion.
Pharmaceuticals accounted for 32.2% of Q1 FY27 revenue, followed by Oil & Gas at 31.4%, Material Science at 16.6%, and Agro at 9.5%.
What drove margins
A strategic pivot towards CRAMS and CEM contracts contributed to strong operating income and margin enhancement during the quarter.
Cost of materials consumed and changes in inventories totaled INR 163.80 crore, employee benefits expense was INR 19.10 crore, and other expenses stood at INR 40.90 crore.
04 · Demand, customers & order book
Where demand is coming from
Completed nine customer and certification audits during Q1 FY27, validating operational and quality standards.
05 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
CEM and CRAMS combined contributed 60% of total revenue during Q1 FY27, moving closer to the company's medium-term target of 70% within the next two years.
Other notable segment contributions in Q1 FY27 included High Performance Photography at 3.7%, Multiple sectors at 3.2%, Coatings at 1.7%, and Sustainability & Renewables at 1.7%.
Geography and market mix
Domestic sales accounted for 62.5% of Q1 FY27 revenue, while exports, including deemed exports and SEZ sales, represented 37.5%.
06 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
Commercial production at Site 3++ commenced, with ongoing ramp-up supporting operational output.
Commercial operations began for the first phase of Site 5, comprising two production blocks, with strong visibility established for the first 10 production blocks.
Projects, capex and execution
Installed 18 new fume hoods in the existing R&D facility and progressed construction on the new R&D building at Site 1 (Catalyst), with completion targeted for Q1 FY28.
07 · Strategy & new businesses
How the company is trying to change its growth mix
R&D expenditure for Q1 FY27 was INR 19.81 crore, amounting to 6.16% of revenue, underpinning new product pipelines in pharmaceuticals, agrochemicals, and material sciences.
08 · Reported developments
What changed operationally
Successful commissioning of Site 5 Phase 1 (two production blocks) and Site 3++ provides immediate revenue visibility for subsequent quarters.
09 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Capital allocation & funding
Finance costs for Q1 FY27 were reported at INR 5.58 crore, reflecting servicing of existing debt obligations.
10 · Beyond the numbers
What changed beyond the numbers
Reported update
Team Demographics
Management highlighted a refreshed organizational team structure with an average employee age of 29 years.
11 · Key Q&A
The quarter, answered directly
What does Aether Industries do?
Aether Industries Limited operates in the specialty chemicals sector, focusing on advanced organic chemistry, complex intermediates, and new-technology commercialization.
What is the clearest takeaway from Q1 FY27?
Aether Industries reported consolidated revenue from operations of INR 326.56 crore for the first quarter ended June 30, 2026, alongside total income of INR 334.25 crore.
What drove revenue or demand?
Growth in Contract and Exclusive Manufacturing (CEM) contracts, alongside price-led demand in Large Scale Manufacturing (LSM), drove overall topline expansion.
What mattered most for margins or profitability?
A strategic pivot towards CRAMS and CEM contracts contributed to strong operating income and margin enhancement during the quarter.
What changed operationally beyond the headline numbers?
Commercial production at Site 3++ commenced, with ongoing ramp-up supporting operational output.
What should the next disclosure help confirm?
Track the commercial revenue ramp-up from the newly commissioned production blocks at Site 5 starting in Q2 FY27.
12 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
13 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Site 5 Revenue Contribution: Track the commercial revenue ramp-up from the newly commissioned production blocks at Site 5 starting in Q2 FY27.
- 02
R&D Building Completion: Monitor construction progress on the new R&D centre at Site 1 ahead of its scheduled completion by Q1 FY28.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.